article thumbnail

Reflections on 2018: Kelly Perdew, Moonshots Capital

socalTECH

Editor's note: As we head into the new year, we've been featuring reflections on 2018 from notable investors, entrepreneurs, and others from Southern California's technology community. What was the biggest news for your firm in 2018? You'll be able to browse all of those contributions here.

Capital 113
article thumbnail

Equity Investment Platform Preparation Best Practices

Startup Professionals Musings

If you are one of the thousands of entrepreneurs who need equity funding to get your startup going (no loans to repay), you are probably overwhelmed at the prospect of finding, contacting and pitching to the huge number of qualified angels and investment groups around the country. File a provisional patent or other intellectual property.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reflections on 2020: Brian Mac Mahon, Expert Dojo

socalTECH

    We became the largest accelerator in Southern California with 80 investments in over 30 countries globally. We now invest in more companies, include better trainers and involve 3 times more investors in the demo days. it's hard to describe just how good our investment, growth, operations and outreach team is.

article thumbnail

Maine’s Largest Hospital Launches Internal Health Tech Accelerator

Tech.Co

Maine Medical Center, Maine’s largest hospital, is investing in their employees and giving them a chance to act on their innovative ideas that could transform healthcare. You need to share ideas, invest jointly, and work in teams to get anything off the ground,” she said. “I The hospital itself has had two patents issued to it. “We

IP 70
article thumbnail

Why Pitching Your Product Is Not Enough For Investors

Startup Professionals Musings

This implies high odds of a scalable business, simply needing an investment to lead to success. Patents, trade secrets, and trademarks are very attractive to investors, since these are not easily overcome by competitors. Of course, investors want to see a positive return on their investment, with timeframes and growth expectations.

Product 58
article thumbnail

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

Xconomy

—Oral arguments in the landmark patent fight over ownership of the gene editing technology CRISPR-Cas9 were set for Dec. Patent and Trademark Office. —Despite the patent fight, CRISPR work continues apace. —Despite the patent fight, CRISPR work continues apace. CRISPR DEVELOPMENTS. 6 at the U.S.

Patents 87